SCOPUS 정보 검색 플랫폼

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 4, Issue 6, 2004, Pages 599-601

Four quadrants of the cost-effectiveness plane: Some considerations on the south-west quadrant

(2) Klok, Rogier M a Postma, Maarten J a

a UNIVERSITY OF GRONINGEN (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDGET; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; MEDICAL DECISION MAKING; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION;

EID: 9944260314 PISSN: 14737167 EISSN: None Source Type: Journal
DOI: 10.1586/14737167.4.6.599 Document Type: Editorial

Times cited : (27)

References (9)

1
- 0031855391
- Healthcare contingent valuation studies: A review and classification of the literature
- Diener A, O'Brien B, Gafni A. Healthcare contingent valuation studies: a review and classification of the literature. Health Econ. 7(4), 313-326 (1998).
- (1998) Health Econ. , vol.7 , Issue.4 , pp. 313-326
- Diener, A.¹ O'Brien, B.² Gafni, A.³

2
- 9944236084
- The economic evaluation of a randomized trial comparing 'test-and-treat' with prompt endoscopy in primary care; the health economics of the SENSE-study
- Klok RM, Arents NL, de Vries R et al. The economic evaluation of a randomized trial comparing 'test-and-treat' with prompt endoscopy in primary care; the health economics of the SENSE-study. Value Health 7(6), 754 (2004).
- (2004) Value Health , vol.7 , Issue.6 , pp. 754
- Klok, R.M.¹ Arents, N.L.² de Vries, R.³

3
- 0036197997
- Is there a kink in consumers' threshold value for cost-effectiveness in healthcare?
- O'Brien BJ, Gertsen K, Willan AR, Faulkner LA. Is there a kink in consumers' threshold value for cost-effectiveness in healthcare? Health Econ. 11, 175-180 (2002).
- (2002) Health Econ. , vol.11 , pp. 175-180
- O'Brien, B.J.¹ Gertsen, K.² Willan, A.R.³ Faulkner, L.A.⁴

4
- 0028509556
- Costs, effects and C/E-ratios alongside a clinical trial
- van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 3(5), 309-319 (1994).
- (1994) Health Econ. , vol.3 , Issue.5 , pp. 309-319
- van Hout, B.A.¹ Al, M.J.² Gordon, G.S.³ Rutten, F.F.⁴

5
- 2442652725
- Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions
- Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 13(5), 405-415 (2004).
- (2004) Health Econ. , vol.13 , Issue.5 , pp. 405-415
- Fenwick, E.¹ O'Brien, B.J.² Briggs, A.³

6
- 0000513914
- Willingness to pay and willingness to accept: How much can they differ?
- Hanemann WM. Willingness to pay and willingness to accept: how much can they differ? Am. Econ. Rev. 18(3), 635-647 (1991).
- (1991) Am. Econ. Rev. , vol.18 , Issue.3 , pp. 635-647
- Hanemann, W.M.¹

7
- 0000125532
- Prospect theory: An analysis of decision under risk
- Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 47(2), 263-291 (1979).
- (1979) Econometrica , vol.47 , Issue.2 , pp. 263-291
- Kahneman, D.¹ Tversky, A.²

8
- 2442716360
- Why cost-effectiveness should trump (clinical) effectiveness: The ethical economics of the South West quadrant
- Dowie J. Why cost-effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant. Health Econ. 13, 453-459 (2004).
- (2004) Health Econ. , vol.13 , pp. 453-459
- Dowie, J.¹

9
- 0036442198
- Theoretical arguments for the discounting of health consequences; where do we go from here?
- Lazaro A. Theoretical arguments for the discounting of health consequences; where do we go from here? PharmacoEconomics 14, 943-961 (2002).
- (2002) PharmacoEconomics , vol.14 , pp. 943-961
- Lazaro, A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.